Table 2:

Selected patient data

Patient No.DiagnosisT2FA MeanADC
1MSC2*0.481.52
C30.811.3
C5*0.520.89
C70.790.8
D4*0.691.08
D7*0.661
2MSC20.50.7
C30.670.92
3SarcoidosisC70.560.76
D7*0.670.84
4MSC6*0.681.04
D5*0.571.17
5MSD10.510.63
D4*0.561.08
D60.581.43
6MSC70.621.02
D7*0.51
7PRNC50.680.92
C70.650.84
D30.830.817
D50.71.12
D70.580.962
8TMD3–D5*0.661.18
9SarcoidosisC30.840.75
C50.710.979
C70.740.878
D50.431.07
D7*0.650.87
D90.520.77
10TMD3*0.60.9
11MSC40.841.12
C60.51.024
D10.830.819
D40.871.001
D6*0.681.107
D80.831.106
12MSD5*0.581.3
13MSC30.50.8
C50.630.85
D70.740.843
D80.840.861
D100.860.937
14SarcoidosisD8*0.331.73
D9*0.322.32
15MSD10.661.13
D20.741
  • Note:—FA indicates fractional anisotropy; ADC, apparent diffusion coefficient; MS, multiple sclerosis; TM, transverse myelitis; PRN, polyradiculoneuritis.

  • * Pathologic level seen on T2-weighted imaging.